Amneal Pharmaceuticals, Inc. AMRX Specialty — Acquisition costs

Other segment segments

Similar metrics at other companies

MLMSpecialties — Business Combination Acquisition Divestiture And Integration Related Costs

$0—

APGSpecialty Services — Acquisitions

$0—

CNASpecialty — Deferred acquisition costs

$454M+2.9%

ESISpecialties — Acquisitions

$163.6M—

NEAcquisition and integration costs

$2.62M-82.5%

AUBAcquisition and integration costs

$9.03M+82.9%

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s specialty — acquisition costs?

Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — acquisition costs of $0 in Q1 2026.

What does specialty — acquisition costs mean?

Non-recurring expenses related to the identification, due diligence, and integration of acquired businesses or product lines into the specialty segment. Tracking these costs helps investors understand the financial impact of inorganic growth strategies.